Inhibition of Human Immunodeficiency Virus Type 1 Replication in Human Cells by Debio-025, a Novel Cyclophilin Binding Agent
Roger G. Ptak(Southern Research Institute), Brigitte Rosenwirth, Urs T. Rüegg(University of Geneva), Andrew P. Halestrap(University of Bristol), Michael Bobardt(Scripps Research Institute), Marie‐Pierre de Béthune(Unknown), Erik De Clercq(Rega Institute for Medical Research), Philippe Gallay(Scripps Research Institute), Dirk Jochmans(Rega Institute for Medical Research), Kamel Besseghir(Debiopharm (Switzerland)), Johan Neyts(Rega Institute for Medical Research), Luke A. Pallansch(Southern Research Institute), Roland M. Wenger, Jean‐Maurice Dumont(Debiopharm (Switzerland)), Piétro Scalfaro(Debiopharm (Switzerland))
Cited by 115
Related Papers
In Vivo Gene Delivery and Stable Transduction of Nondividing Cells by a Lentiviral Vector
|Science|1996|4.9k
The proton-linked monocarboxylate transporter (MCT) family: structure, function and regulation
|Biochemical Journal|1999|1.3k
Association between mutations in a thyroid hormone transporter and severe X-linked psychomotor retardation
|The Lancet|2004|707
Therapeutic strategies for COVID-19: progress and lessons learned
|Nature Reviews Drug Discovery|2023|671
Antiviral agents active against influenza A viruses
|Nature Reviews Drug Discovery|2006|666